Miyoshi Muscular Dystrophy 3: Genetic Testing as a Beacon of Hope
Explore how genetic testing aids in early diagnosis and personalized treatment of Miyoshi Muscular Dystrophy 3, offering hope and improved outcomes for patients.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Mastering the Mysteries of Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A2
Explore the complexities of muscular dystrophy-dystroglycanopathy type A2, where genetic testing aids in diagnosis, management, and personalized patient care.
Mapping the Mysteries: Understanding Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A5
Explore muscular dystrophy-dystroglycanopathy type A5, a rare genetic disorder. Learn how genetic testing aids in diagnosis, personalized care, and research.
Mapping the Mystery: Understanding Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A6 Through Genetic Testing
Explore muscular dystrophy-dystroglycanopathy Type A6, a rare genetic disorder affecting muscles, brain, and eyes. Learn about genetic testing for accurate diagnosis.
Mapping the Mystery: Muscular Dystrophy-Dystroglycanopathy (Congenital with Intellectual Disability), Type B1
Explore how genetic testing aids in diagnosing muscular dystrophy-dystroglycanopathy, guiding treatment plans, family planning, and advancing research for targeted therapies.
Mapping the Mysteries of Muscular Dystrophy-Dystroglycanopathy (Congenital with Intellectual Disability), Type B3
Explore the genetic complexity of Muscular Dystrophy-Dystroglycanopathy Type B3. Learn how genetic testing aids in diagnosis, management, and family planning.
Mastering Muscular Dystrophy-Dystroglycanopathy: Genetic Testing's Role in Type B4
Muscular dystrophy type B4 genetic testing aids in diagnosis, management, family planning, and advances research for targeted treatments and improved patient outcomes.
Nephronophthisis-like Nephropathy 1: Navigating Genetic Testing for Insightful Diagnosis
Unravel nephronophthisis-like nephropathy with genetic testing. Early diagnosis, personalized treatment, and family planning insights enhance patient care.